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1. Introduction 
Leishmaniasis is a chronic disease caused by parasites from Leishmania genus and still 
represents a severe public health problem in the world and the incidence is increasing 
(Desjeux, 2004). There is no effective vaccine for prevention of any form of leishmaniasis and 
programs of prevention and drug therapy are the main mechanisms for disease control. On 
the other hand, current chemotherapy is the only way to treat cases of leishmaniasis. Since 
the 1940s, the pentavalent antimony compounds (e.g., Glucantime, Pentostam, or branded 
pentavalent formulations) have been the mainstays of antileishmanial therapy (Aït-Oudhia 
et al., 2011). Although these drugs are usually effective, they produce serious side effects, 
present difficulties of administration and high cost, the parasite persists in the scars of 
clinically cured patients (Schubach et al., 1998), and drug resistance has been observed 
(Castillo et al., 2010). Second-line drugs are used in areas with high rates of 
unresponsiveness to antimonial treatment or when it was not possible to administrate it. 
However, these drugs are even more toxic than antimony compounds and expensive, and 
these include pentamidine, amphotericin B, anti-fungal, allopurinol, and more recently, 
miltefosine, paramomicine and sitamaquine. Furthermore, they have low therapeutic index 
when compared to antimonial compounds (Almeida and Santos, 2011). Instead of 
determining treatment based on rational therapeutic indications, treatment of choice is 
frequently dictated by economic considerations and in a large majority of countries, 
chemotherapeutic approaches for all forms of leishmaniasis rely on the use of pentavalent 
antimonial compounds (Aït-Oudhia et al., 2011). The mechanism of pentavalent antimony 
compounds action is the inhibition of glycolytic pathway and ┚-oxidation enzymes of the 
parasites (Baiocco et al., 2009), but being a heavy metal it is non-selective and it is believed 
to interfere with other metabolic pathways of parasites and hosts. Furthermore, these drugs 
can interact with the zinc finger domain of proteins, and many proteins have this motif in 
their tridimensional structures (Demicheli et al., 2008). 
Attempts to develop vaccines against Leishmania and drugs to treat cases of leishmaniasis 
are a continuing effort in search for novel parasite antigens. Various candidate molecules 
have also been tested and some degrees of protection against different species of Leishmania 
infection were observed (Chawla and Madhubala, 2010). In order to develop a rational drug 
www.intechopen.com
 Applications of Immunocytochemistry 
 
268 
for leishmaniasis chemotherapy, the biochemistry of Leishmania parasites needs to be better 
understood for the identification of these strategic targets. Immunocytochemistry strategies 
have localized these targets in Leishmania, providing valuable information about the roles of 
these molecules in the parasite life cycle and in the pathogenesis of leishmaniasis. So, the 
purpose of this chapter is to focus on the employment of immunolabeling and electron 
microscopy in order to localize proteases which are critical for the survival of the Leishmania 
parasites. Furthermore, this chapter will cover aspects of leishmaniasis epidemiology, 
Leishmania morphology, potential drug targets in Leishmania and proteases as targets in 
Leishmania, highlighting the function and subcellular localization of cysteine proteases, gp 63 
metalloprotease and serine proteases.    
2. Leishmaniasis and Leishmania 
Leishmaniasis is one of the most significant neglected diseases and occurs in the tropical and 
subtropical regions of America, Asia, Africa and Europe. This disease is considered to be 
endemic in 88 countries, 72 of which are developing countries (Kaye and Scott, 2011). About 
350 million people are at risk of Leishmania infection and as many as 12 million people in the 
world are believed to be currently infected. Approximately 1–2 million estimated new cases 
every year with the annual mortality rate of about 60,000 (Okwor and Uzonna, 2009). 
Leishmaniasis is a disease associated with the poverty, environmental changes, such as 
deforestation, building of dams, urbanization, and the accompanying migration of non-
immune people to endemic areas. However, due to underreporting - notification of 
leishmaniasis is compulsory in only 32 of the 88 affected countries - and misdiagnosis, actual 
case numbers are expected to be higher. Furthermore, most affected people are hidden 
because the social stigma associated with deformities and disfigurement scars and due to 
they live in remote areas. Leishmaniasis-related disabilities impose a great social burden, 
and reduce economic productivity (WHO, accessed in August 15th, 2011). Over the past 20 
years, leishmaniases have increasingly been recognized as an opportunistic infection in HIV-
infected patients, with Leishmania–HIV co-infection common in areas where both diseases 
are endemic. The highest prevalence of co-infection cases occurs mostly in Spain and 
southwestern Europe, among injectable drug users. The presence of both pathogens 
concomitantly in the same host cell (macrophage) influences the expression and 
multiplication of both pathogens. HIV-1 infection increases the risk of developing visceral 
leishmaniasis by 100 to 2,300 times in endemic areas, reduces the likelihood of a therapeutic 
response and greatly increases the probability of relapse.  Moreover, Leishmania promotes an 
increment in viral load and a more rapid progression to AIDS, which reduces life 
expectancy of infected patients (Ezra et al., 2010). 
Clinical manifestations of leishmaniasis range from self-healing cutaneous, mucocutaneous 
skin ulcers and a long-lasting diffuse cutaneous in cellular-mediated immune response 
deficient hosts to a lethal visceral form (i.e., visceral leishmaniasis or kala-azar) and post-
kala-azar dermal leishmaniasis. The clinical spectrum of this disease is associated with the 
species of Leishmania involved (Desjeux, 2004). Today, about 30 species of protozoan of the 
Leishmania genus (Order Kinetoplastida and Family Tripanosomatidae) are known and 
approximately 20 are pathogenic for humans and are the causative agents of the “Old” and 
“New Worlds” leishmaniasis. All members of the genus Leishmania Ross, 1903 are parasites 
of mammals. The two subgenera, Leishmania and Viannia, are separated on the basis of their 
location in the vector’s intestine and isoenzyme analysis was used to define species 
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complexes within the subgenera. These species generally present different epidemiological 
and clinical characteristics related to different genetic and phenotypic profiles.  All species 
of the subgenus Viannia were isolated in the ‘New World’, while those of the subgenus 
Leishmania were isolated from the “Old World”, except for species of the L. (L.) mexicana 
complex, L. (L.) hertigi, L. (L.) deanei—which are found in the ‘New World’ only—and L. (L.) 
infantum/chagasi and L. (L.) major, which are found in both the “New” and “Old Worlds” 
(Bañuls et al., 2007). 
These parasites can be transmitted by female sandflies via anthroponotic or zoonotic cycles, 
transplacental, blood transfusion and through contaminated needles by injecting drug users. 
Vector transmission is the commonest way of parasite dissemination (Molina et al., 2003). 
Leishmania parasites have a dimorphic life-cycle: The flagellated, motile forms of Leishmania 
spp. are called promastigotes (Figure 1 A). They are found into the very alkaline digestive 
tract of the sandfly and progress through various morphologically distinct stages of 
differentiation to ultimately become the non-dividing, infectious ‘metacyclic’ promastigotes 
that are transmitted during a sandfly bite. These ‘metacyclic’ promastigotes are phagocyted 
by professional phagocytes such as macrophages and, inside these cells parasites survive 
and multiply as amastigotes (Figure 1B), a smaller form of Leishmania with non-exteriorized 
flagellum and very metabolic active (Seifert, 2011).  
All members of the genus Leishmania are obligated intracellular parasites of several 
mammalian cells and survive under very acid, oxidant and hostile conditions into 
parasitophorous vacuoles environment, and they have evolved several mechanisms to avoid 
their degradation (Mougneu et al., 2011). These mechanisms include specific organelles and 
molecules, such as proteases, that are secreted or are intracellular expressed (Silva-López et 
al., 2005; Yao, 2003). Special organelles found in trypanosomatid Leishmania include 
mitochondrion and kinetoplast (De Souza et al., 2009a), megasomes (De Souza et al. 2009b) 
and glycosomes (Michels et al., 2006). Some of these organelles and the evolutive forms of 
Leishmania are schematically represented in the figure 1.    
3. Potential drug targets in Leishmania 
One of the features in the process of drug development is target identification in a biological 
pathway. In theory, during this identification in a pathogen, it is important that the putative 
target should be either absent in the host or substantially different from the host homolog so 
that it can be exploited as a drug target. Trypanosomatids, phylogenetically, branch out 
quite early from the higher eukaryotes. In fact, their cell organization is significantly 
different from the mammalian cells and thus, it is possible to find targets that are unique to 
these pathogens. Secondly, the target selected should be absolutely necessary for the 
survival of the pathogen. It is also important to consider the stage of the life-cycle of the 
pathogen in which the target protein is expressed. So, the most important targets are 
enzymes, since they regulate a specific biochemical pathway and their active sites can bind 
specific inhibitors that can be designed or found in the nature. A good enzyme target means 
that its inhibition should lead to loss in cell viability. Furthermore, it is important that the 
target selected should be assayable (Shukla et al., 2010). Many enzymes have been 
investigated in their capacity to control or regulate essential Leishmania biochemical 
pathways or some mechanisms that guarantee the parasite survival and proliferation for 
infection maintenance, such as the enzymes that regulate or participate in sterol biosynthesis, 
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Fig. 1. Schematic representation of Leishmania sp forms and their organelles. A) Amastigotes. 
B) Promastigotes. F, flagellum; K, kinetoplast; N, nucleus; FP, flagellar pocket; ER, 
endoplasmic reticulum; M, mitochondrion; mt, microtubules; G, Golgi; L, lysosome 
(adapted by the author from Rey, 1991).   
hypusine biosynthesis, glycolysis, purine salvage, glycosylphosphatidylinositol 
biosynthesis, folate biosynthesis and glyoxalase and trypanothione system or special 
enzymes such as protein kinases, topoisomerases and proteases (Chandra et al., 2010; 
Chawla and Madhubala, 2010).  
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Before discussing about the proteases, which is the purpose of this chapter, it is worth to 
mention about some enzymatic systems that are considered good targets in Leishmania 
(Table 1). Sterols are important components of the cell membrane and are essential to the 
cellular function. The sterol biosynthesis of trypanosomatids is very different from humans, 
because these parasites synthesize ergosterol and 24-methyl sterols, instead of cholesterol. 
The extensively studied squalene synthase and D24,25-sterol methyltransferase enzymes, 
only present in trypanosomatids, perform crucial roles in regulation of sterol metabolism 
and their specific inhibitors have showed anti-proliferative and growth inhibition effects of 
Leishmania in vitro (Goto et al., 2009).  
Leishmania compartmentalize several important metabolic systems in special peroxisomes 
which are designated glycosomes. These organelles contain seven of the ten enzymes of 
glycolytic pathway, the pentose-phosphate pathway, ┚-oxidation of fatty acids, purine 
salvage, biosynthetic pathways for pyrimidines, ether-lipids and squalenes (Moyersoen et 
al., 2004). The glycolytic enzymes of Leishmania exhibited large phylogenetic distance with 
the mammalian hosts and, for this reasons, specific inhibitors have been designed for the 
most important regulator enzyme, the glyceraldehyde-3-phosphate dehydrogenase. These 
compounds inhibited growth of L. (L.) mexicana by blocking the energy production, since 
glycolysis is the most important source of energy for these parasites (Saunders et al., 2010). 
Furthermore, the biogenesis of these organelles occurs via peroxins self-interactions and the 
reduction of peroxin expression or their self-interaction inhibition induced the Leishmania 
death (Michels et al., 2006). 
Protozoans of Leishmania genus lack the metabolic machinery to the synthesis of purine 
nucleotides and the parasites have to depend upon the purine salvage system to utilize 
purine from their hosts. Three phosphoribosyltransferases were identified in Leishmania, and 
the hypoxanthine-guanine phosphoribosyl transferase is the most important enzyme 
involved in purine salvage (Carter et al., 2008). Various inhibitors have been designed to 
target this enzyme due to its difference in substrate specificity with the host enzyme. 
Allopurinol is the most common inhibitor that is phosphorylated by the enzyme and 
incorporated into nucleic acid, leading to selective death of the parasite (Loiseau and Bories, 
2006). Allopurinol has been shown to be effective against cutaneous and visceral 
leishmaniasis, but when used with other anti-leishmanial drugs was found to be even more 
effective (Castillo et al., 2011; Almeida and Santos, 2011). Besides, purines are transported 
through the parasite cell surface by nucleoside transporters and these transporters also 
uptake toxic nucleoside analogs which inhibits the parasite growth (Al-Salabi and Koning, 
2005). So, these transporters represent an alternative strategy for interfering in Leishmania 
purine metabolism and develop novel drugs to leishmaniasis treatment. Some of these 
synthetic and natural products that inhibited specifically crucial steps in a metabolic 
pathway of Leishmania inducing the parasite death and reducing leishmaniatic lesion 
progression in susceptible animal models have been tested in controlled clinical trials. These 
compounds have showed different degrees of efficacy, therapeutic index and in general 
caused less adverse effects than that observed in patients treated with antimonials or with 
the second-line drugs that is currently being used for leishmaniasis treatment (Fernandes 
Rodrigues et al., 2008; Valdivieso et al., 2010; Almeida and Santos, 2011; Pereira et al., 2011).  
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 Target enzymes  Methods of location Subcellular 
location  
Biological functions 
Squalene synthase and    
D24,25-sterol methyl-
transferase.  
Subcellular 
fractionation  
Membrane, 
glycosomes 
and 
mitochondrial/ 
microsomal 
vesicles.  
Sterol biosynthesis, 
which are components 
of the cell membrane 
and Leishmania 
signaling (Goto et al., 
2009). 
Deoxyhypusine synthase and
deoxyhypusine hydroxylase  
not applied not determined Hypusine biosynthesis 
that are involved in 
Leishmania proliferation, 
differentiation, and 
biosynthesis of 
macromolecules 
(Chawla et al., 2010). 
Glyceraldehyde-3-phosphate 
dehydrogenase 
Subcellular 
fractionation 
  
Glycosomes Regulates the glycolysis 
that is the most 
important metabolic 
pathway in Leishmania 
ATP supply (Saunders 
et al., 2010). 
Hypoxanthine-guanine 
phosphoribosyl transferase 
Subcellular 
fractionation 
Glycosomes Purine salvage for 
nucleotides and 
nucleosides (Carter et 
al., 2008).
Glycosylphosphatidylinositol 
biosynthetic enzymes 
Subcellular 
fractionation 
immunofluorescence 
Tubular 
subdomain of 
the 
endoplasmic 
reticulum 
Glycosylphosphatidyl-
inositol acts as a 
membrane anchor for 
many cell-surface 
proteins of eukaryotes 
(Ilgoutz et al., 1999). 
methylene-tetrahydrofolate 
dehydrogenase/cyclohydrolase 
and formyl-tetrahydrofolate 
ligase.  
Subcellular 
fractionation western 
blotting  
immunofluorescence 
Cytosol Formyl-
tetrahydrofolate 
biosynthesis. Folates 
are used in purine 
biosynthesis and    
mitochondrial initiator 
methionyl-
tRNAMetformylation 
(Vickers et al., 2009) 
Glyoxalase system immunofluorescence kinetoplast catalyzes the formation 
of d-lactate from 
methylglyoxal, a toxic 
product of glycolysis, 
using trypanothione as 
substrate (Chauhan  
and Madhubala, 2009) 
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 Target enzymes  Methods of location Subcellular 
location  
Biological functions 
Trypanothione system Subcellular 
fractionation 
immunofluorescence 
mitochondria 
and cytosol 
H2O2-detoxification 
(Krauth-Siegel et al., 
2007) 
Protein kinases immunofluorescence 
immunocytochemistry
cytosol Enzymatic activity 
regulation by addition 
of phosphate (Baqui et 
al., 2000).    
Topoisomerases immunofluorescence Kinetoplast 
mitochondria 
Topoisomerases I 
catalyze the cleavage of 
one strand of DNA, 
whereas 
topoisomerases II 
catalyze the cleavage of 
a double-stranded 
DNA, requiring ATP as 
cofactor (Banerjee et al, 
2011) 
Proteases Subcellular 
fractionation 
immunofluorescence 
immunocytochemistry
Membrane, 
flagellar 
pocket,  
megasomes 
and endocytic/ 
exocytic 
vesicles 
Hydrolysis of peptide 
bonds in proteins and 
peptides. They are 
crucial in Leishmania life 
cycle, in host-parasite 
relationship, and in 
leishmaniasis 
pathogenesis (Silva-
López et al., 2010a, b). 
  
Table 1. Main protein targets in Leishmania sp. 
4. Proteases as targets in Leishmania  
Proteases, also known as peptidases, are hydrolytic enzymes that cleave peptide bounds in 
proteins and peptides, releasing peptides with variable sizes and free amino acids. Unlike 
most enzymes, proteases lack specificity toward a substrate, i.e., a specific protein. Instead, 
they are very specific for a peptide containing the scissile peptide bond and the amino acids 
involved in the neighborhood of the peptide bonds instead of the whole molecule (Garcia-
Carreno and Del Toro, 1997). They are ubiquitously found in all living beings from 
unicellular to higher organisms and are the most studied class of enzyme (Shinoda and 
Miyoshi, 2011). They participate in various physiological processes through the modification 
of proteins, such as digestion of food proteins, tissue remodeling, neuropeptides, hormones, 
and proenzyme processing, cellular metabolism by proteasomes, blood clotting, 
complement activation cascade reactions, metabolism regulation and a vast number of other 
biological phenomena as well as they are encoded by 2% of all genes in an organism (López-
Otín and Bond, 2008). These enzymes are grossly classified as: exopeptidases which act on 
the ends of protein substrates and are designated as amino-or carboxypeptidases, and 
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endopeptidases acting on the interior of protein substrates. Endopeptidases classification 
rests on the type of residue at the active site: the hydroxyl group of serine proteases (EC 
3.4.21) and the sulfidryl group of cysteine proteases (EC 3.4.22) are the nucleophile during 
catalysis, while activated water is the nucleophile for aspartic (EC 3.4.23), and 
metalloproteases (EC. 3.4.24) (Barret, 1994). Proteases are further classified according to their 
structure in families and Clans. A family is a set of homologous proteolytic enzymes that 
show significant similarity in amino acid sequence, and homologous families that have 
arisen from a single evolutionary origin of peptidases are grouped together in a Clan 
(Rawlings et al., 2010). The different types of proteases have particular characteristics that 
allow their proteolysis to function in a huge diversity of environments. They are very well 
adapted to surrounding conditions and can act in acid or basic pH, hypo and hyper 
osmolarity, higher or lower temperatures, and for these reasons they can be found in all 
cellular compartments and in all organs of the higher organisms.   
Besides their physiological necessity, proteases are potentially hazardous to their 
proteinaceous content and their activity must be precisely controlled by the respective cell 
or organism. However if this activity is unregulated it can destroy cells, tissues and organs 
and can kill organisms. So, the control has to be very efficient and is normally achieved by 
regulated expression/secretion, zymogen production, enzyme activation, degradation of the 
mature enzymes and most important by protease inhibitors, that can react with the active 
site or other domain of the enzyme, impeding its capacity to bond and hydrolyze the 
substrate. In general, there are two types of inhibitors: (a) small non-proteinaceous 
compounds, secreted by microorganisms that irreversibly modify the amino acid residue of 
the enzyme active site, and (b) the huge number of natural inhibitors, which are pseudo 
substrates isolated from various cells, tissues and organisms often that accumulate in high 
quantities in plant seeds, and various body fluids. Inhibitors of different types occur 
commonly among living organisms and viruses, which stresses their ultimate role in 
physiological processes (Otlewski et al., 1999; Krowarsch et al., 2003; Silva-López, 2009). 
These inhibitors are valuable tools for investigation of the biochemical properties and the 
biological functions of proteases, besides they are employed in the treatment of many 
diseases and are under investigation as chemotheraphic in the treatment of leishmaniasis 
(Silva-López et al., 2007; Valdivieso et al., 2010; Olivier and Hassani, 2010; Pereira et al., 
2011).  
Many studies have focused their attention on the crucial roles of proteases in the Leishmania 
life cycle, in the host-parasite relationship, and in the pathogenesis of leishmaniasis. These 
enzymes are important virulence factors and they have been implicated in a wide variety of 
adaptation mechanisms for in-host parasite survival, which include modulation of the host 
immune system, invasion and destruction of host connective tissues, enabling parasites to 
migrate to specific sites for growth and development and/or acquire essential nutrients that 
guarantee survival and proliferation for infection maintenance (Mottran et al., 2004; 
McKerrow et al., 2006; Matos Guedes et al., 2010; Gómez and Olivier, 2010; Silva-López, 
2010 b; Yao, 2010; Swenerton et al, 2010; Swenerton et al, 2011) and their importance has 
been confirmed through findings that specific protease inhibitors kills Leishmania parasites 
(Silva-López et al., 2007). 
It is important to point out that the subcellular location of Leishmania proteases provides 
knowledge about the function of these enzymes in the parasite physiology, and 
consequently if they are potential targets to develop new chemotherapy for leishmaniasis 
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treatment. There are some strategies to determine the proteases localization and 
immunocytochemistry techniques are the most capable for specifically detecting and 
localizing macromolecules within thin sections of any cell type, preserving the structure 
of most antigenic sites and retaining the antigenicity (Herman, 1988). Using these 
strategies, many proteases were successfully localized in both forms of Leishmania and 
their importance in the parasite physiology and infection was elucidated. Cysteine 
proteases, gp63 metalloprotease and, more recently serine proteases are the most 
investigated proteolytic enzymes of the genus Leishmania and some considerations about 
their functions and subcellular localization using immunocytochemistry studies will be 
focused in this chapter.   
4.1 Cysteine proteases 
North and Coombs in 1981 reported for the first time the proteolytic activity in both 
promastigote and amastigote forms of Leishmania. They demonstrated that the highest 
activity was found in amastigotes and belonged to the cysteine protease class (North and 
Coombs, 1981), and since then these enzymes were extensively studied. So, at this time 
proteases were also considered virulence factors in Leishmania, because as in other 
parasites these enzymes have a recognized role in the mechanisms of invasion, survival 
and migration in host tissues (Kozar, 1961). The immunocytochemistry constitute an 
universal assay capable of detecting and localizing macromolecules in any cell type using 
specific unlabeled primary antibody directed at the antigen of interest and then indirectly 
localizing the primary antibody with a second label consisting of antibodies conjugated to 
an electron-dense material (Lunedo et al., 2011) and considerations about this valuable 
technique will be done at the end of this chapter. These cysteine proteases were localized 
for the first time in amastigotes of L. (L.) mexicana, a member of mexicana complex, by the 
post-embedding immunocytochemistry assays using as the primary antibody IgG fraction 
purified from a rabbit antiserum against L. (L.) mexicana amastigote cysteine protease and 
the anti-rabbit IgG immunospecificity complexed with gold colloidal (5-10 nm diameter) 
as the secondary antibody. The acid ester hydrolase arylsulfatase (EC 3.1.6.1) was also 
employed as a marker of lysosomes using 4-nitrocatechol sulphate as substrate and 
barium chloride as capture agent, forming electron dense barium deposits at reaction sites 
(the enzyme location), that is visualized by electron microscopy. These enzymes, cysteine 
protease and arylsulfatase, were found into larges organelles that contain putative 
lysosomal enzymes that was previously named "megasomes" (Pupkins et al., 1986). 
Megasomes are large lysosome-like structures, previously described in amastigote forms 
of Leishmania belonging to the mexicana complex, whose major constituents are the 
cysteine proteinases (Ueda-Nakamura et al., 2001). It is important to point out is that L. 
(L.) mexicana has the ability to cause both a cutaneous and a diffused cutaneous 
leishmaniasis in South and Central America and, is a member of the mexicana complex 
that is formed by L. (L.) amazonensis, L. (L.) pifanoi, L. (L.) garnhami, L. (L.) venezuelensis and 
L. (L.) forattinni. Besides, L. (L.) amazonensis is one of the most important etiologic agent 
that causes cutaneous and diffuse cutaneous leishmaniasis in Latin America, L. (L.) 
donovani causes cutaneous and mainly visceral diseases in the “Old World” and L. (L.) 
major is associated with cutaneous and mucocutaneous leishmaniasis in the “Old World” 
(Bañuls et al., 2007). Comparative studies with amastigotes of L. (L.) amazonensis, L. (L.) 
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donovani, revealed that L. (L.) amazonensis was similar to L. (L.) mexicana in possessing both 
high content of cysteine protease activity in amastigotes and a large numbers of 
megasomes, whereas the other two species lacked both of these features (González et al., 
2008). The presence of numerous megasomes in the amastigote is a characteristic of the 
Leishmania subgenus, particularly of mexicana complex (Pupkis et al., 1986).  
Further studies also employing light microscopy and post-embedding 
immunocytochemistry and the weak base 3-(2,4 dinitroanilino)-3'-amino-N-
methyldipropylamine (DAMP) as a probe, localized acidic compartments of L. (L.) 
amazonensis amastigotes since it is known that DAMP concentrates in acidic compartments 
of cultured cells. This probe was mainly accumulated within megasomes and in dense 
inclusion vacuoles, proving that megasomes have a low pH maintained by an active 
process, besides suggesting that these organelles may be targets for amino acid 
derivatives (Antoine, 1988). It is important to consider some immunocytochemical aspects 
to localize the DAMP probe in Leishmania. In this assay the anti-DNP (2,4-Dinitrophenol) 
immune serum was prepared in rabbit by injecting human IgG-DNP mixed with a 
complete Freund´s adjuvant. After fixation and reaction with an antibody against-DNP it 
can be visualized by anti-rabbit IgG conjugated to gold (7 nm) particles as secondary 
antibody (Antoine, 1988).    
The immunocytochemistry is a powerful technique for investigating the location of specific 
proteins in a cell. The biosynthesis, enzymatic processing, and immunocytochemical 
localization of a major cysteine protease of L. (L.) pifanoi, were investigated employing L. (L.) 
pifanoi axenic cultured amastigotes and L. (L.) amazonensis lesion-derived and, both 
polyclonal antisera and monoclonal antibodies specifically recognized either the mature 
cysteine protease or the carboxyl-terminal extension domain (Duboise et al., 1994) using 
post-embedding protocols.  L. (L.) pifanoi is another member of the mexicana complex that 
causes cutaneous leishmaniasis in humans (Colemares et al., 2002). It is important to 
emphasize that all proteases are synthetized as a high molecular weight zymogen without 
proteolytic activity and the formation of mature protease involves the processing of the 
zymogen by cleavage of specific peptides bounds and removal of C or N-terminal domains 
(Neurath, 1984). Electron microscopic immunolocalization of both catalytic and C-terminal 
domains showed intense labeling of megasomes, indicating that this cleavage occurs in this 
organelle. Furthermore, specific cysteine proteinase inhibitors blocked the processing of 
cysteine protease in vivo and also inhibited parasite cell division. Moreover, a low level of 
the mature protease was also associated with the flagellar pocket and plasma membrane. 
Consistent with this observation, a low level secretion of this cysteine protease into the 
culture medium was detected (Duboise et al., 1994). It is known that the flagellar pocket is a 
secluded extracellular compartment in the anterior portion of trypanosomatids, formed by 
an invagination of the plasma membrane at the base of the flagellum and is the only part of 
the cell surface that supports exocytosis and endocytic traffic in Leishmania and other 
trypanosomatids because of its lack of attached microtubules (De Souza, 2006; Bonhivers et 
al., 2008). The flagellar pocket membrane is an obligatory intermediary station for 
membrane-bound molecules trafficking between intracellular membranes and the cell 
surface and vice-versa (Overath et al., 1997).  
The processing and trafficking of cysteine proteases were also studied in L. mexicana (L.) 
using axenic amastigotes and anti-cysteine protease B antiserum and the study showed that 
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the proteolytic processing of zymogen and maturation of the enzyme is redundant and 
required other types of cysteine proteases and is not easy to paralyze it with inhibitors. 
However, cysteine proteases are addressed to megasomes via the flagellar pocket and 
therefore differs from trafficking in mammalian cells (Brooks et al., 2000), making this 
pathway an important target to block the Leishmania growth. 
Post-embedding immunocytochemistry assays, using antibody against Leishmania cysteine 
protease, was also employed to prove the importance of these proteases in the pathogenesis 
of leishmaniasis. This Leishmania protease was detected in the lesion sections from infected 
mice by L. (L.) mexicana amastigotes, possibly due to amastigotes lysis and releasing of 
megasomes content into the parasitophorous vacuole of infected macrophages. These 
proteases were also found extracellularly in the host mice tissue presumably as a result of 
macrophage rupture and appear to persist within the lesion, where they may damage host 
cells and the extracellular matrix proteins (Ilg et al., 1994). Additionally, it was 
demonstrated that metacyclic promastigotes of L. (L.) mexicana, the infective form of 
parasite, exhibited higher proteolytic activity than multiplicative promastigotes and 
amastigotes, expressing quantitatively more and with a distinct pattern composed of 
multiple proteases (Bates et al., 1994). Suggesting that the expression of proteases varies 
according to evolutive forms of parasite and are important both to survival within the host, 
and infection of the mammalian cells.    
The information about the cellular location and distribution of cysteine proteases in 
Leishmania parasites draws attention to the importance of these enzymes in the parasite 
physiology. Further studies have clarified the biochemical properties and functions of 
these enzymes, as well as their gene expression (Ramos et al., 2004; Hide and Bañuls, 
2008). Cysteine proteases are the major proteolytic activity in Leishmania and they are 
required for survival and growth of protozoan into fagolisosomes and leishmaniasis 
pathogenesis (Marín-Villa et al., 2008), because of this, they are considered the most 
important virulence factors of Leishmania since they influence the interaction between the 
parasite and mammalian host (Mottram, et al., 2004). Genome analysis has revealed the 
great diversity of cysteine proteases of Leishmania (Hide and Bañuls, 2008) and they are 
distributed in eight families within clan CA. Family C1 contains cysteine protease A and 
cysteine protease B, which are both cathepsin L-like, and cysteine protease C, which is 
cathepsin B-like. Cysteine protease B is unusual as it has a 100-amino acid C-terminal 
extension in comparison with most cysteine proteases of the group, and exists as multiple 
isoenzymes, which are encoded by a tandem array of similar cysteine protease B genes 
located in a single locus (the arrays comprise eight genes in L. major) (Saffari and 
Mohabatkar, 2009).  
Although the exact roles of cysteine proteases in Leishmania pathogenesis are unclear, it has 
been demonstrated that Leishmania cannot grow within macrophages in the presence of 
specific protease inhibitors (Duboise et al., 1994). Besides, it was demonstrated that L. (L.) 
chagasi cathepsin L-like cysteine protease (Ldccys2) are specifically expressed in amastigote 
and is necessary for macrophage infection and for survival of the parasite within 
macrophage cells (Mundondi et al., 2005). The role of the same enzyme, Ldccys2, was 
investigated in L. (L.) pifanoi and L. (L.) amazonensis employing post-embedding 
immunocytochemistry using antibodies against recombinant C-terminal extension of 
Ldccys2 and anti-Ldccys2 catalytic domain both of L. (L.) pifanoi and 10nm-gold labeled goat 
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anti-rabbit as a secondary antibody (Marín-Villa et al, 2008). The polyclonal antibody 
specific to Ldccys2 C-terminal extension recognized cysteine proteases from both parasites 
and also detected a predominant location of this peptide in the lysosome and flagellar 
pocket of cultured axenic amastigotes of both parasite species. However, its location was 
shifted towards the surface of the parasites during macrophage infection. This same 
antibody significantly reduced macrophage infection in both L. (L.) pifanoi and L. (L.) 
amazonensis, confirming that Ldccys2 C-terminal domain is essential for macrophage 
infection. Importantly, the entrance into macrophages is mediated by the endocytosis of 
opsonized parasites, which are recognized by membrane receptors present on the 
macrophage surface (Rittig and Bogdan, 2000). Besides, confirming previous reports that C-
terminal extensions of proteases are highly immunogenic in T. cruzi, antibodies against this 
peptide in sera of leishmaniasis patients was detected. This study suggests an essential role 
for Leishmania cysteine proteinases C-terminal extensions at early stages of infection (Marín-
Villa et al, 2008). Other studies demonstrated that when Leishmania parasites are exposed to 
various stress conditions, such as heat shock and oxidant agents, they release cysteine 
protease C, a cathepsin B-like enzyme, which is involved in the cell death cascade of the 
parasite (El-Fadili et al., 2010). 
Beside the roles described above, Leishmania cysteine proteases, specifically of type B, can 
modulate the immune response of mammalian hosts to favor parasite survival and 
proliferation.  They are themselves immunogenic, since L. (L.) mexicana cysteine proteases 
are T cell immunogen, resulting in the development of potentially protective Thl cell lines. 
This finding suggests that the cysteine proteases could also be a vaccine candidate and that 
homologous enzymes in other parasites species may also be so (Khoshgoo et al., 2008; 
Saffari and Mohabatkar, 2009; Fedelli et al., 2010, Doroud et al, 2011).  
Many evidences indicate that Leishmania cysteine proteases could be targets to develop 
rational drugs to treat leishmaniasis, so specific inhibitors were produced by combinatorial 
synthetic chemistry optimization using models of both L. (L.) major cathepsin B and L, 
through a structure based drug design screen (Scheidt et al, 1998). These compounds were 
tested against Leishmania cysteine proteases and both amastigotes and promastigotes (Selzer 
et al., 1999; Schurigt et al., 2010). The electron microscopy and post-embedding immuno-
cytochemical localization strategies were also used to study the effect of hydrazine 
derivatives in parasite and to confirm target protease localization at the site of inhibitor-
induced abnormalities (Selzer et al., 1999). After 24 h of treatment, ultrastructural alterations 
included autophagic vacuoles, undigested cell debris, and multivesicular bodies into dilated 
megasomes and flagellar pocket were observed. These abnormalities resemble alterations 
seen in lysosomal storage diseases caused by lysosomal hydrolases deficiency. Using a 
polyclonal antiserum raised against the native L. (L.) major cysteine protease B and a 
secondary goat antibody to rabbit IgG conjugated with 10-nm gold particles it was possible 
to observe, only in treated promastigotes, heavily labeled in dilated megasomes and in 
flagellar pocket, confirming the specific effect of inhibitors in the site of cysteine proteases 
location (Selzer et al., 1999). Other cysteine protease inhibitors from natural resources, such 
as plant cystatins, or chemically synthetized, such as pseudopeptide substrate analogues, 
derivatives of aziridine, triazoles, ┙-ketoheterocycles and NO-donors, were assayed against 
Leishmania. These compounds provided different degrees of inhibition in promastigote 
growth and viability, amastigote survival and reduction in the macrophages infection rate 
(Duboise et al., 1994; Pral et al., 1996; Alves et al., 2001; Tornøe et al., 2004; Ascenzi et al., 
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2004; Ordóñez-Gutiérrez et al., 2009, Schurigt et al., 2010; Steert et al., 2010). Although 
cysteine proteases inhibitors look promising, the activity of the three cysteine proteases 
families would need to be blocked to completely prevent parasite invasion or replication in 
the host cells and lesion development, and non-selective inhibitors can also affect the host 
cysteine proteases. An alternative to this problem would be to develop inhibitors which 
prevent the cysteine proteases precursor processing resulting in a retrograde accumulation 
of unprocessed proteases and proteins in organelles of endocytic/exocytic pathway which 
lead to the parasite´s death. 
4.2 The major surface protein or gp 63 metalloprotease 
After the discovery of cysteine proteases in both amastigote and promastigote forms of 
Leishmania, a protease of 63 kDa was purified and characterized as the major surface protein 
of promastigotes also called glycoprotein 63 (gp63) (Etges et al., 1986). This protease was 
identified in different species of Leishmania, including L. (L.) major, L. (L.) donovani, L. (L.) 
infantum, L. (L.) tropica, L. (L.) mexicana, L. (L.)  amazonensis, L. (V.) braziliensis, and L. (L.) 
enriettii, and was proved to be structurally and functionally conserved in Old and New 
World Leishmania species (González et al., 2008). It is important to note that L. (L.) major, L. 
(L.) donovani, L. (L.) infantum and L. (L.) tropica cause cutaneous and mucocutaneous 
leishmaniasis in the “Old World” while L. (L.) enriettii is non-pathogenic for humans 
(Bouvier et al., 1987). In amastigote forms of L. (L.) mexicana the surface glycoprotein gp63 
was localized by post-embedding immunocytochemistry strategies using a monoclonal 
antibody against promastigote gp63 of L. (L.) mexicana and goat anti-mouse IgG conjugated 
with 5-nm gold particles. This protease was located in amastigote surface, however the label 
was more intense within the flagellar pocket of the parasite, which is also involved with 
endocytosis and secretion of molecules (Overath et al., 1997), and is primarily associated 
with dense material in the lumen of this pocket (Medina-Acosta et al., 1989). The isolation 
and analysis of surface proteins from lesion amastigotes indicated that gp63 is also the most 
abundant protein on the amastigote surface (Medina-Acosta et al., 1989). 
Gp63 (EC 3.4.24.36) is a zinc metalloprotease that accounts for about 1% of the total protein 
in promastigotes of Leishmania and is also termed as major surface protease, surface acid 
protease, promastigote surface protease, and leishmanolysin. This metalloproteases belongs 
to the M8 family of endopeptidases, sharing several characteristics with mammalian matrix 
metalloproteases (Yao et al., 2003). This enzyme hydrolyzes only proteins, but not peptides, 
at various pH values (acid, neutral or basic) depending on the protein substrate (Tzinia and 
Soteriadou, 1991). These observations suggest that gp63 can catalysis in different 
environment conditions, such as in the sandfly midgut and macrophage parasitophorous 
vacuoles, because this enzyme is present in both promastigotes and amastigotes Leishmania 
surfaces. Since then, the functions of this strategic protease were extensively investigated. 
Gp63 plays several important roles in the pathogenesis of leishmaniasis, including (i) 
evasion of complement-mediated lysis, (ii) facilitation of macrophage infection by 
promastigotes, (iii) interaction with the extracellular matrix, (iv) inhibition of natural killer 
cellular functions, (v) resistance to antimicrobial peptide killing, (vi) degradation of 
macrophage and fibroblast cytosolic proteins, and (vii) promotion of survival of intracellular 
amastigotes (Yao, 2010). The gp63 overexpression caused increased host infection and 
intracellular parasite survival, on the other hand, gp63-deficient parasites infecting 
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macrophages mice, showed a diminished infection and survival (Yao, 2003). Thus, gp63 
contributes to parasite virulence by exerting a novel type of control over complement 
fixation. Organisms expressing gp63 can exploit the opsonic properties of complement while 
avoiding its lytic effects (Brittingham et al., 1995).  
The major surface protease is also important in the Leishmania-sandfly interaction. The 
development and forward migration of Leishmania parasites in the sandfly gut was 
accompanied by morphological transformation to highly mobile, non-dividing 'metacyclic' 
forms. Metacyclogenesis is associated with developmentally regulated changes in 
expression of gp63 and its expression in L. (L.) major promastigotes surface was studied by 
post-embedding immunocytochemical analysis using the GP63-specific monoclonal 
antibodies which demonstrates a clear expression from 2 to 7 days post-blood feeding 
(Davies et al., 1990). This protease proved to be essential in the development and survival of 
parasite into sandfly gut, because it degrades hemoglobin and other proteins in the blood 
meals, thereby providing nutrients needed for the growth of promastigotes and protects 
promastigotes from degradation by the midgut digestive enzymes (Hajmová et al., 2004). 
Besides all the functions of Gp63 in Leishmania-hosts interactions, the native protein, 
recombinant or specific peptides from this cleavage was able to elicit a protective immunity 
to many species of Leishmania infection in a variety of animal models (Handman, et al., 1990; 
Abdelhak et al., 1995; Bhowmick et al., 2008; Mazumder et al., 2011). The immunogenicity 
and antigenicity of gp63 is very well known. Additionally, it was immunolocalized in the 
lumen of flagellar pocket indicating that this protease is secreted by Leishmania parasites 
and, and it explains why can be found antibodies against gp63 in patient sera with 
leishmaniasis (Sayal et al., 1994). For these reasons, gp63 is one of the major candidate 
molecules for vaccine development against leishmaniasis (Chawla and Madhubala, 2010). 
Unlike the Leishmania cysteine proteases inhibitors that are extensively investigated for drug 
development to leishmaniasis treatment, studies about gp63 inhibitors did not identify any 
compound that block the biological functions of this protease and, as the immunogenicity 
and antigenicity of gp63 has always been recognized many studies were conducted to 
develop vaccines against Leishmania using gp63 or its derivatives as immunogen. 
4.3 Serine proteases 
Although serine proteases are the most studied enzymes in all living organisms, the first 
studies about proteases of Leishmania identified important proteolytic activity belonged to 
cysteine protease class, as discussed before (North and Coombs, 1981). Almost two decades 
later the activity of a serine peptidase was purified and characterized from soluble extracts 
of L. (L.) amazonensis promastigotes (Andrade et al., 1998). Unlike other proteases described 
in Leishmania, it does not hydrolyze proteins or large peptides, but cleaves only small 
peptides substrates, at the carboxyl side of basic residues and aromatic residues preceding 
basic residues, which characterizes the enzyme as an oligopeptidase. This was the first study 
that reports the presence of serine peptidase activity in Leishmania and even more an 
oligopeptidase (Andrade et al., 1998). It is important to consider that Trypanosoma species do 
not express enzymes showing serine protease activities, but only serine oligopeptidases with 
specific functions in many steps of mammalian cell invasion (Silva-López et al., 2008; 
Alvarez et al., 2011).  
www.intechopen.com
Immunocytochemistry of Proteases  
in the Study of Leishmania Physiology and Host-Parasite Interaction 
 
281 
Besides the oligopeptidase activity, L. (L.) amazonensis showed expressive activity of serine 
proteases (Silva-López et al., 2004; Silva- López and De Simone, 2004 a, b; Silva-López et al., 
2005). This type of proteolytic enzymes were first obtained from a cell-free supernatant of 
axenic L. (L.) amazonensis promastigotes and was proven to be originated from the parasite 
despite having been purified from culture supernatant. The post-embedding 
immunocytochemistry strategy was critical to demonstrate the relationship between the 
extracellular serine protease and promastigotes, using a rabbit antiserum raised against a 
heat-inactivated 56-kDa serine protease obtained from culture supernatant and purified 
using aprotinin-agarose affinity chromatography, and anti-rabbit antibody labeled with 10-
nm gold particles (Silva-López et al., 2004). In this study amastigotes from lesions of infected 
mice were also used in order to investigate the subcellular location of this serine protease 
and infer possible functions for this enzyme. It was possible to observe that the antibody 
reacted poorly with the parasite surface and moderately with internal structures in most 
samples (about 95%) of both forms of the parasite (Figure 2).  
In promastigotes, gold particle labeling showed the serine protease to be predominantly 
located in the flagellar pocket and in vesicular structures which are morphologically similar 
to the compartments found in mammalian endocytic/exocytic pathways (Figure 2 A and B). 
It is worth noting, as mentioned previously, that the flagellar pocket is a secluded 
extracellular compartment in the anterior portion of Leishmania formed by an invagination 
of the plasma membrane at the base of the flagellum and is the only part of the cell surface 
that supports exocytosis and endocytic traffic of molecules (De Souza, 2006; Bonhivers et al., 
2008). This pocket is an obligatory intermediary station for membrane-bound molecules 
trafficking between intracellular membranes and the cell surface and vice-versa (Overath et 
al., 1997). Both membrane-bound and secreted proteins appear on the cell surface, 
underscoring the role of this membrane in delivery of proteins to the cell surface and 
exterior (Bonhivers et al., 2008). In amastigotes, the enzyme was detected not only in 
subcellular structures similar to those of promastigotes, such as the flagellar pocket and 
cytoplasmic vesicles (Figure 2), but also in electron-dense structures corresponding to 
megasomes (Figure 2 C and D). As commented before, megasomes are large lysosome-like 
structures and are the main sites of proteolytic activity in Leishmania belonging to the 
mexicana complex, whose major constituents are the cysteine proteases, which results in 
differentiation process participation and in parasite intracellular survival (Ueda-Nakamura 
et al. 2002).   
The processing and trafficking of cysteine proteases, the best studied lysosomal Leishmania 
proteases, has been reported in L. pifanoi and L. (L.) mexicana and is targeted to megasomes 
via the flagellar pocket and has been previously discussed (Duboise et al., 1994; Brooks et al. 
2000). These results demonstrated that L. (L.) amazonensis secretes a 56-kDa serine protease 
into the culture supernatant through the flagellar pocket with the participation of different 
components that resemble mammalian endocytic/exocytic organelles. Furthermore, the fact 
that this enzyme is located in megasomes, where cysteine proteases are also found, indicate 
that the serine protease can contribute, in association with the cysteine proteases, to 
maintain the parasite life cycle and leishmaniasis pathogenesis and so, also represents a 
novel target in Leishmania parasite. This secreted serine protease was further purified and 
their biochemical characteristics and kinetics parameters were investigated. This enzyme is a 
dimeric protein of about 115 kDa, with subunits of 56kDa, very well adapted to the 
environment conditions and certainly contributes to survival and growth of the parasite 
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Fig. 2. Subcellular location of serine protease in L. (L.) amazonensis promastigotes. (A) 
Promastigote forms showing immunolabeling at flagellar pocket. In both forms, the cell 
surface was poorly labeled (Arrowhead). (C) Amastigotes displayed moderate labeling in 
flagellar pocket, cytoplasmic vesicles (Arrows) and in megasomes. Scale bars; A and C: 2.0 
m. High magnification images of the anterior region of (B) promastigote and (D) and 
amastigote showing immunolabeling at cytoplasmic vesicles (Arrows) that subtending the 
flagellar pocket in both forms of L. (L.)  amazonensis. Scale bars; B and D: 3.2 m. Flagellar 
pocket (P), flagellum (F), kinetoplast (K), megasome (M) and nucleus (N) (Silva-López et al., 
2004).  
inside their hosts, since it is found in promastigotes and amastigotes forms of Leishmania 
(Silva-López et al., 2005). 
Two other serine proteases were also purified from water and detergent soluble intracellular 
extracts of L. (L.) amazonensis promastigotes and exhibited different properties and must 
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perform distinct functions in the Leishmania metabolism and physiology (Silva- López and De 
Simone, 2004 a and b). The subcellular location of the 68-kDa serine protease, an enzyme 
purified from the water soluble intracellular extracts of promastigote parasites, was performed 
by electron microscopy post-embedding immunocytochemistry, using the antiserum raised in 
rabbit by injecting the 68-kDa serine protease purified as previously described (Silva-López 
and Giovanni De Simone 2004 a). As observed in the figure 3, the antibody reacted against the 
parasite cytoplasmic membrane and internal structures in the analyzed cells. Cytoplasmic gold 
particles are seen bound to the external surface and to the flagellar pocket membrane (Figure 3 
A), and were localized predominantly in cytoplasmic vesicular structures morphologically 
similar to that of the endocytic/ exocytic pathways and tubulovesicular structures close to the 
flagellar pocket region (Figure 3 B and C) (Morgado-Díaz, et al., 2005).  
 
Fig. 3. Subcellular localization of 68 kDa serine protease in L. (L.) amazonensis promastigotes. 
A: gold particles are seen bound to the external surface (arrowheads) and to the flagellar 
pocket membrane, B: high magnification showing labeling in cytoplasmic vesicles and 
tubulovesicular structures close to the flagellar pocket (arrows). C: high magnification 
showing labeling (arrow) in cytoplasmic vesicles. P: flagellar pocket; F: flagellum; K: 
Kinetoplast; N: nucleus. Bar = 0.25 m (Morgado-Díaz, et al., 2005). 
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It is important to compare the localization of both 68 kDa intracellular and 56 kDa secreted 
serine proteases: While the 68 kDa enzyme is mainly located in membranes of intracellular 
compartments and plasma membrane, the 56 kDa protease, previously described, reacted 
poorly with the parasite surface and moderately with internal structures. However, it was 
predominantly located in the flagellar pocket, megasomes and structures that are 
morphologically similar to the compartments that are found in mammalian 
endocytic/exocytic pathways (Silva-López et al. 2004), which justified the released into the 
extracellular environment. 
The activity of serine proteases were also isolated from aqueous, detergent and extracellular 
extracts of L. (V.) braziliensis promastigotes employing aprotinin-agarose affinity 
chromatography (Matos Guedes at al., 2007). L. (V.) braziliensis is the major species of 
Leishmania associated with cutaneous and mucosal forms of leishmaniasis in Brazil and 
Latin America (Bañuls et al., 2007). These proteases display some biochemical similarities 
with L. (L.) amazonensis serine proteases, demonstrating a conservation of this class of 
proteolytic activity in the Leishmania genus and suggesting similar subcellular location and 
functions. This was the first study to report the purification of a serine protease from L. (V.) 
braziliensis (Matos Guedes at al., 2007). 
The first evidences of the possible functions of these serine proteases in Leishmania were 
obtained using specific serine protease inhibitors. These compounds induced parasite death, 
with regard to time and doses dependence and, significant morphological alterations. These 
structural changes were observed in the region of the flagellar pocket and included the 
appearance of vesicles, which were accompanied by bleb formations of the membrane that 
covers this pocket which was importantly altered (Silva-López et al., 2007). These effects in 
the flagellar pocket (a structure of intense exocytic/endocytic activities) indicated that these 
compounds are endocyted through this structure, and inhibited the serine proteases which 
are located in this pocket, as previously described by immunocytochemical studies (Silva-
López et al., 2004). In the cytoplasm the presence of vesicles that resemble autophagic 
vacuoles was also noted. The autophagy is a catabolic process involving the degradation of 
a cell's own components through the lysosomal  machinery and is required for normal 
turnover, starvation, stress responses differentiation, development and in a certain type of 
cell death (Kiel, 2010). Serine proteases inhibitors caused cell death of L. (L.) amazonensis 
promastigotes inducing the formation of autophagic vacuoles, since the features associated 
with Leishmania apoptosis were not observed (Paris et al., 2004).  No modification was found 
in any of the other cellular structures of the parasites treated with these inhibitors. 
Furthermore, all parasites exhibited shape alterations (Silva-López et al., 2007). Although the 
described results indicate that these enzymes are essential for parasite survival, their 
functions in Leishmania physiology are unclear. If these enzymes participate in the 
exocytosis/endocytosis pathway through the processing of intracellular proteins or even in 
the maintenance of morphological organization of Leishmania remains to be elucidated. 
However, these findings suggest that Leishmania serine proteases appear to be promising 
targets for the development of specific inhibitors for leishmaniasis chemotherapy. 
Serine protease activities were also described for L. (L.) chagasi, the causative agent of 
visceral leishmaniasis in Latin America (Bañuls et al., 2007). These enzymes were isolated 
from aqueous, detergent soluble and culture supernatant of L. (L.) chagasi promastigote 
extracts and respectively named as LCSII, LCSI and LCSIII. The characterization of these 
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enzymes employed similar strategies used for L. (L.) amazonensis serine proteases (Silva-
López et al., 2010a). The same rabbit antiserum against the 56-kDa extracellular protease and 
anti-rabbit antibody labeled with 10-nm gold particles were used to determine the 
subcellular localization of the serine proteases in L. (L.) chagasi promastigotes employing 
post-embedding immunocytochemistry strategies. The reactivity of this antiserum was first 
assayed with all three serine proteases by immunoblotting proteases and indicated that 
serine proteases of both parasites are related proteins. The antibody did not react with the 
parasite surface but strongly with internal structures in most samples. The gold particles 
labeling confirmed that serine proteases are located in the flagellar pocket region and 
intracellular vesicles (Figure 4), demonstrating that LCSIII which was obtained from culture 
supernatant, follow the same route of secretion to the extracellular environment utilizing the 
flagellar pocket. L. (L.) chagasi serine proteases were also located in contractile vacuoles and 
in vesicles located at the posterior region of the parasite body, next to the nucleus. The 
contractile vacuoles are intracellular vesicles immediately adjacent to the plasma membrane 
of the flagellar pocket and are involved in fluid secretion via this pocket (Linder and 
Staehelin, 1979). Other serine peptidases, such as the extracellular serine peptidases from L. 
(L.) amazonensis (Silva-López et al., 2004) (Figure 2) and T. cruzi (Silva-López et al., 2008) 
employed the same route of secretion, since they were also evidenced in the flagellar pocket 
and contractile vacuoles.  
Notably, the endocytic pathway of the Leishmania promastigotes comprises a network of 
tubular endosomes, multivesicular bodies and un unusual multivesicular tubule (MVT)–
lysosome, originally observed in L. (L.) mexicana (Alberio et al., 2004), and are the main sites 
of proteolytic activity in Leishmania, as well as being crucial for the differentiation process 
and parasite intracellular survival (Ueda-Nakamura et al., 2007).  
Recent studies demonstrated that L. (L.) donovani express a very similar secreted serine 
protease like L. (L.) amazonensis which was also located in the flagellar pocket of 
promastigotes by post-embedding immunogold labeling using anti-115-kDa serine protease 
antibody and a gold 10 nm particles conjugated secondary antibody. Besides, this enzyme is 
particularly expressed in virulent strains and is also associated with the metacyclic stage of 
L. (L.) donovani promastigotes. It is postulated that 115 kDa serine protease could be a 
potential vaccine candidate since it plays important roles in the macrophage infection and is 
secreted to extracellular environments (Choudhury et al., 2010).  
Besides the expression of secreted 115-kDa serine protease, two other serine proteases were 
identified and characterized in L. (L.) donovani promastigotes, using biochemical and 
molecular strategies: subtilisin (Swenerton et al., 2010) and oligopeptidase B (Swenerton et 
al., 2011) serine proteases. The functions of Leishmania subtilisin (Clan SB, family S8) was 
studied in parasites with gene knock-out for this enzyme, which resulted in reduced ability 
to undergo promastigote to amastigote differentiation in vitro and amastigotes revealed 
abnormal membrane structures, retained flagella, and increased binucleation. These “knock-
out” parasites displayed reduced virulence in both hamster and murine infection models. 
Furthermore, proteomic analysis indicated that Leishmania subtilisin is the maturase for 
tryparedoxin peroxidases that detoxifies reactive oxygen intermediates and maintain redox 
homeostasis that is essential for Leishmania virulence (Swenerton et al., 2010). Using similar 
proteomic strategies was demonstrated that L. (L.) donovani oligopeptidase B (Clan SC, 
family S9A) regulate the function of enolase, since parasites “knock-out” of this peptidase  
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Fig. 4. Immunolocalization of serine proteases in promastigotes of L. (L) chagasi. 
Representative ultrathin section of promastigotes labeled with polyclonal antiserum to 56-
kDa L. amazonensis serine protease. (a) Gold particles are seen bound to the flagellar pocket 
membrane (arrow) and into intracellular vesicles (asterisk) of L. chagasi promastigote. (b-c) 
High magnification images showing labeling in the anterior region of promastigote, in 
flagellar pocket (arrow head), contractile vacuoles and into intracellular vesicles (arrow 
head and asterisk), respectively. Flagellar pocket (fp), contractile vacuole (cv), vesicle (v) 
and nucleus (n) (Silva-López et al., 2010a).  
showed enolase abnormally increased but enzymatically inactive. Aside from its classic role 
in carbohydrate metabolism, enolase was found to localize in cytoplasmic membranes, 
where it binds host plasminogen and functions as a virulence factor for several pathogens. 
As expected, there was a striking alteration in macrophage responses to Leishmania when 
oligopeptidase B was deleted, so the enzyme interfered in parasite enolase activity and 
immune evasion. Besides, these “knock-out” parasites displayed decreased virulence in the 
murine footpad infection model (Swenerton et al., 2011). 
It is also important to emphasize the roles of serine proteases in the host immune system 
modulation. Mice vaccination with soluble proteases isolated from L. (L.) amazonensis 
promastigote antigens directly activated IL-4, IL-10 and TGF-beta production by immune 
cells and primed mice to respond to parasite challenge with a strong Jones-Mote cutaneous 
hypersensitivity reaction, and increased susceptibility to infection. So, serine proteases are 
key components of L. (L.) amazonensis promastigote antigens responsible for disease-
www.intechopen.com
Immunocytochemistry of Proteases  
in the Study of Leishmania Physiology and Host-Parasite Interaction 
 
287 
promoting immunity (Matos Guedes et al., 2010) and besides being important targets to 
drug development against Leishmania, they are also vaccine candidates for leishmaniasis. 
In addition to the proteases already discussed, aspartic protease activity was identified and 
characterized in L. (L.) mexicana promastigotes (Valdivieso et al., 2007). This activity was 
target of anti proliferative effect on Leishmania sp. promastigotes and axenic amastigotes by 
HIV aspartyl-protease inhibitors, Ac-Leu-Val-Phenylalaninal, Saquinavir mesylate and 
Nelfinavir. The latter two compounds are currently used as part of antiretroviral therapy. 
This effect appears to be the result of cell division blockage. In addition, these drugs induced 
in culture a decrease in the percentage of co-infected HIV/Leishmania monocytes and 
amastigotes of Leishmania per macrophage. The finding of a dose-dependent inhibition of 
Leishmania aspartyl-protease activity by these drugs allows us to propose this activity as the 
drug parasite target. A direct action of these HIV aspartyl-protease inhibitors on Leishmania 
parasites would be correlated with the effect that highly active antiretroviral therapy has 
had in the decrease of HIV/Leishmania co-infection, opening an interesting perspective for 
new drugs research development based on this novel parasite protease family (Valdivieso et 
al., 2010).  
It is very clear that the employment of specific protease inhibitors could block Leishmania 
proteolytic activity and interfere in the progression of leishmaniasis. A recent study 
demonstrated that host uncontrolled matrix metalloprotease activity in the cutaneous 
lesions caused by L. (V.) braziliensis may result in intense tissue degradation and, 
consequently, poor healing wounds, which were associated with unsatisfactory response to 
antimonials treatment (Maretti-Mira et al., 2011). Thus a pharmaceutical formulation 
containing protease inhibitors can inhibit both host and parasite proteases and helps heal 
leishmaniac lesions. 
5. Technical considerations 
All immunocytochemical experiments begin with tissue fixation, which serves the dual 
purpose of preserving the cellular structure and the in vivo distribution of antigens. 
However, antigens are chemically modified by fixation and further denatured by 
dehydration and embedment. Formaldehyde fixation preserves most antigenic sites but it is 
reversible and it does not maintain good ultrastructure. Osmium post fixation is essential to 
preserve membrane structure and ultrastructural detail; unfortunately, osmium often 
irreversibly destroys antigenic sites. In immunocytochemical protocols to localize serine 
proteases in L. (L.) amazonensis and L. (L.) chagasi, the parasites were fixed in 4% 
paraformaldehyde/1% glutaraldehyde in 0.1M sodium cacodylate buffer, pH 7.3 (Silva-
López et al., 2004; Morgado-Díaz et al. 2005; Silva-López et al., 2010a). The samples were 
dehydrated in methanol and embedded at progressively lowered temperature in Lowicryl 
K4M resin. Lowicryl is a hydrophilic acrylic resin that tolerates partial dehydration and is 
processed and photopolymerized at subfreezing temperatures. The hydrophilic properties 
of Lowicryl result in excellent antigen retention and consequently in high label density, 
specificity, and low background (Herman, 1988). After embedment, thin sections were 
collected on 400 mesh uncoated nickel grids, incubated for 30 min at room temperature in 
phosphate buffered saline (PBS) containing 1.5% bovine serum albumin and 0.01% Tween 
20, pH 8.0 (blocking buffer) in order to block unspecific bounds. The grids were incubated 
for 60 min in the presence of the primary antibodies: anti-56 kDa extracellular serine 
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protease or anti-68 kDa intracellular serine protease diluted in blocking buffer. Both 
antibodies were produced using similar protocols. Serine proteases were purified using 
affinity chromatography on aprotinin-agarose columns (Silva-López and De Simone, 2004b; 
Silva-López et al., 2005). The antiserum was raised in rabbit by injecting the homogeneous 
heat inactivated purified serine proteases emulsified in complete (first booster) and 
incomplete (subsequent boosters) Freud’s adjuvant. After the fourth injection the antibody 
reactivity was checked by immunoblotting. So, grids containing embedded parasites were 
finally incubated for 60 min with goat anti-rabbit antibody labeled with 10-nm gold 
particles. The grids were subsequently washed with PBS and distilled water, stained with 
uranyl acetate and lead citrate and observed in a Zeiss EM10C transmission electron 
microscope (Silva-López et al., 2004; Morgado-Díaz et al. 2005; Silva-López et al., 2010a). The 
quality of antibodies is essential to obtain reliable results in immunocytochemistry assays, 
since they must be specific and sensitive enough to bind the antigen of interest in the 
cellular structure without labeling other intracellular sites that do not contain the antigen. 
Furthermore, to localize antigens by electron microscopy, it is necessary to impart electron 
density to the bound antibodies. Colloidal gold probes have been extensively adopted for 
use in post-embedding and pre-embedding immunocytochemistry assays (Bendayan et al. 
1987).  
Immunocytochemical experiments may be accomplished with various procedures for pre- 
or post-embedding labeling. Each method offers distinct advantages and disadvantages 
regarding to specificity, density of antigen labeling, and structural preservation. Pre-
embedding immunocytochemistry assays requires cryoprotected tissue and labeled with 
primary and indirect electron-dense labels which enter the tissue by diffusion. The labeled 
tissue is then embedded, sectioned, and examined. The primary advantage is the excellent 
antigen retention as the consequence of few pre-labeling and processing steps. The 
disadvantages result from the poor penetration of both primary antibodies and secondary 
labels into the tissue, limiting the label to a gradient in the superficial few micrometers, and 
require costly instrumentation. Post-embedding immunocytochemistry is the most 
employed technique in most electron microscopy subcellular location studies and was 
discussed above. In these procedures tissues are fixed, dehydrated, and embedded in plastic 
using protocols similar to those of conventional EM. Thin plastic sections are labeled by 
immersion in solutions of primary antibodies followed by electron-dense second label. The 
main advantages are that the skills and methods are similar to those employed in 
conventional EM, and no specialized equipment beyond that found in any EM laboratory is 
required (Herman, 1988).  
6. Concluding remarks 
The immunocytochemistry is a technique of choice that permits routine and reproducible 
localization of most moderately abundant antigens using specific antibodies against certain 
antigens. The subcellular location of enzymes suggests their function in the metabolism of 
specific organelle, cell or organism. The immunocytochemical localization of Leishmania 
proteases in megasomes, flagellar pocket, cytoplasmic membrane, contractile vacuoles, 
cytoplasmic vesicles, tubulovesicular structures and as secreted enzymes into the 
extracellular environment indicates the versatility of these proteases. They participate in 
exocytic/endocytic pathways, in processing of endogenous proteins or enzymes, in the 
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digestion of exogenous proteins for parasite nutrition or signaling. The localization of 
Leishmania proteases in membrane or in the extracellular medium suggests that these 
enzymes could be important mediators with their hosts, and thus modulate a host immune 
response. Since Leishmania proteases perform crucial roles in parasite physiology and in the 
host-parasite interaction, they are absolutely necessary for the survival of the pathogen and 
the leishmaniasis progression and, in addition they are substantially different from the host 
homolog. So, they are considered important targets in Leishmania. Furthermore, specific 
protease inhibitors induced important alterations in parasite morphology, reduced the 
viability and growth of Leishmania and killed axenic promastigotes and amastigotes and 
intracellular amastigotes thus becoming a promising candidate for leishmaniasis treatment 
(Silva-López et al., 2007; Valdivieso et al., 2010; Olivier & Hassani, 2010; Pereira et al., 2011). 
In conclusion, immunocytochemical strategies contributed and continue to contribute for 
the specific identification of targets in Leishmania which is a rational approach for drug 
development in the leishmaniasis treatment.     
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